Delafloxacin Meglumine is a fluoroquinolone antibiotic used in clinical and therapeutic settings to treat acute bacterial skin and skin structure infections, as well as community-acquired bacterial pneumonia.… Read more


Delafloxacin Meglumine is a fluoroquinolone antibiotic used in clinical and therapeutic settings to treat acute bacterial skin and skin structure infections, as well as community-acquired bacterial pneumonia. Laboratories rely on high-quality reference standards of Delafloxacin Meglumine, along with its related impurities, metabolites, and stable isotope-labelled compounds, to conduct precise analytical testing and rigorous quality control. These materials are essential for impurity profiling, allowing researchers to identify and quantify degradation products and synthesis by-products during method validation and stability studies. By utilizing these characterized reference materials, pharmaceutical laboratories ensure the accuracy and reliability of their assays, supporting the development and safety assessment of antibiotic treatments.